Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001209191-18-050283

Director bought 12,000,000 shares at $1.67 ($20,000,400)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Behbahani Ali Director 2018-09-07 Purchase +12,000,000 $1.67 $20,000,400 12,000,000 I
Open-market purchases · 12,000,000 sh · avg $1.67 · $20,000,400
Loading xslF345X03/doc4.xml…